Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Evommune (EVMN) Shares Outstanding (Weighted Average) (2024 - 2025)

Evommune (EVMN) has disclosed Shares Outstanding (Weighted Average) for 2 consecutive years, with $6.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 306.86% to $6.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $6.1 million, a 306.86% increase, with the full-year FY2025 number at $6.1 million, up 306.86% from a year prior.
  • Shares Outstanding (Weighted Average) was $6.1 million for Q4 2025 at Evommune, up from $1.5 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $6.1 million in Q4 2025 to a low of $1.5 million in Q3 2024.